198 related articles for article (PubMed ID: 37524733)
1. Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.
Yousefnejad F; Mohammadi-Moghadam-Goozali M; Sayahi MH; Halimi M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Asadi M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
Sci Rep; 2023 Jul; 13(1):12397. PubMed ID: 37524733
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Sharafi Z; Faramarzi MA; Rastegar H; Nasli Esfahani E; Bandarian F; Ranjbar Rashidi P; Rahimi R; Biglar M; Mahdavi M; Larijani B
Mol Divers; 2021 May; 25(2):877-888. PubMed ID: 32189236
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors.
Noori M; Davoodi A; Iraji A; Dastyafteh N; Khalili M; Asadi M; Mohammadi Khanaposhtani M; Mojtabavi S; Dianatpour M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
Sci Rep; 2022 Aug; 12(1):14019. PubMed ID: 35982225
[TBL] [Abstract][Full Text] [Related]
7. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents.
Emadi M; Halimi M; Moazzam A; Hosseini S; Mojtabavi S; Faramarzi MA; Ghadimi R; Moghadamnia AA; Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Mahdavi M
Sci Rep; 2023 Jun; 13(1):10030. PubMed ID: 37340010
[TBL] [Abstract][Full Text] [Related]
9. 2,5-Disubstituted furan derivatives containing imidazole, triazole or tetrazole moiety as potent α-glucosidase inhibitors.
He M; Li YJ; Shao J; Fu C; Li YS; Cui ZN
Bioorg Chem; 2023 Feb; 131():106298. PubMed ID: 36455481
[TBL] [Abstract][Full Text] [Related]
10. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as α-glucosidase inhibitors.
Ritu ; Sharma P; Gupta GD; Asati V
Bioorg Chem; 2023 Oct; 139():106750. PubMed ID: 37499530
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
14. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
15. Alpha-glucosidase inhibitory and hypoglycemic effects of imidazole-bearing thioquinoline derivatives with different substituents: In silico, in vitro, and in vivo evaluations.
Azmi A; Noori M; Khalili Ghomi M; Nazari Montazer M; Iraji A; Dastyafteh N; Oliyaei N; Khoramjouy M; Rezaei Z; Javanshir S; Mojtabavi S; Faramarzi MA; Asadi M; Faizi M; Mahdavi M
Bioorg Chem; 2024 Mar; 144():107106. PubMed ID: 38244380
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B
Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes.
Askarzadeh M; Azizian H; Adib M; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Sajjadi-Jazi SM; Larijani B; Hamedifar H; Mahdavi M
Sci Rep; 2022 Jun; 12(1):10569. PubMed ID: 35732907
[TBL] [Abstract][Full Text] [Related]
18. Designing Click One-Pot Synthesis and Antidiabetic Studies of 1,2,3-Triazole Derivatives.
Shafique K; Farrukh A; Mahmood Ali T; Qasim S; Jafri L; Abd-Rabboh HSM; Al-Anazy MM; Kalsoom S
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049866
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids.
Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P
Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
